AI assistant
Sending…
CORCEPT THERAPEUTICS INC — Director's Dealing 2012
Apr 2, 2012
30681_dirs_2012-04-02_2ba93cc0-14f1-4d80-af1d-85d824b4d52b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-03-29
Reporting Person: COOK JOSEPH C JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-29 | Common stock | X | 134617 | $2.96 | Acquired | 1060210 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-29 | Warrants | $2.96 | X | 134617 | Disposed | 2013-04-21 | Common stock (134617) | Direct |
| 2012-03-29 | Warrants | $4.05 | P | 134617 | Acquired | 2015-03-29 | Common stock (134617) | Direct |
Footnotes
F1: Issuance of common stock upon exercise of warrants in accordance with the Warrant Purchase Agreement dated as of March 25, 2012.
F2: Acquired from the issuer pursuant to a Warrant Purchase Agreement dated March 25, 2012 whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued in April 2010.
More from CORCEPT THERAPEUTICS INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18